Antibody-Drug Conjugates Take Their Place On The ASCO 2023 Stage

 
• By Andrew McConaghie

Investment from big and small players against existing and novel targets is making antibody-drug conjugates one of the fastest-growing fields in oncology, as attested by their presence at the upcoming ASCO meeting.    

ASCO 2019
ASCO Meeting Will Hear Many ADC Updates

More from ASCO

More from Conferences